Pfizer Wins FDA Approval for New Ulcerative Colitis Pill

The treatment, to be marketed at Velsipity, is one of a number of new products that Pfizer expects to bring in a combined $20 billion in potential annual revenue by 2030.#velsipity #pfizer
Source: Reuters: Health - Category: Consumer Health News Source Type: news